THORATEC HEARTMATE 3 LVAS IMPLANT KIT
Device
Abbott Laboratories
Total Payments
$9.9M
Transactions
42,230
Doctors
9,492
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $2.1M | 12,517 | 4,734 |
| 2023 | $3.1M | 15,425 | 4,663 |
| 2022 | $4.7M | 14,288 | 3,729 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $4.6M | 1,444 | 46.2% |
| Food and Beverage | $2.1M | 34,602 | 20.9% |
| Consulting Fee | $1.7M | 1,370 | 17.6% |
| Travel and Lodging | $962,225 | 4,053 | 9.7% |
| Space rental or facility fees (teaching hospital only) | $157,498 | 20 | 1.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $145,623 | 122 | 1.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $117,587 | 130 | 1.2% |
| Education | $113,203 | 485 | 1.1% |
| Grant | $19,818 | 4 | 0.2% |
Payments by Type
General
$5.3M
40,786 transactions
Research
$4.6M
1,444 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Antiplatelet Removal and HemocompatIbility Events in the HeartMate 3 Pump | Abbott Laboratories | $2.1M | 0 |
| Antiplatelet Removal and Hemocompatibility Events with the HeartMate 3 Pump IDE Study (ARIES) | Abbott Laboratories | $996,209 | 0 |
| Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical Techniques Other Than Full Median Sternotomy | Abbott Laboratories | $476,396 | 0 |
| Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow Percutaneous Left Ventricular Support Device (SHIELD II) | Abbott Laboratories | $186,928 | 0 |
| MOMENTUM 3 CAP Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3 Continued Access Protocol | Abbott Laboratories | $101,317 | 0 |
| Evaluation of the Hemocompatibility of the Direct Oral Anticoagulant Apixaban in Patients with Heartmate 3 Left Ventricular Assist Devices (DOAC-LVAD) | Abbott Laboratories | $100,000 | 0 |
| Evaluation of the hemocompatibility of the Direct Oral Anti-Coagulant apixaban in patients with HeartMate 3 Left Ventricular Assist Devices (DOAC LVAD) | Abbott Laboratories | $75,000 | 0 |
| MOMENTUM 3 Pivotal Cohort Extended Follow-up Post-Approval Study | Abbott Laboratories | $64,925 | 0 |
| Nutritional Optimization in LVAD (NOL) Trial | Abbott Laboratories | $62,925 | 0 |
| Machine Learning to Distinguish Instantaneous Risk of Gastrointestinal Bleeding and Stroke in LVAD Patients | Abbott Laboratories | $60,525 | 0 |
| Assessment of Right Ventricular Electrophysiology as a Predictor of RV Failure in Pulmonary Hypertension and after Left Ventricular Assist Device Implantation | Abbott Laboratories | $47,000 | 0 |
| Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical SWIFT HM3 PMS (SWIFT) | Abbott Laboratories | $44,913 | 0 |
| Human/?Machine Interface: What the HeartMate 3 Device Tells Us about the Future | Abbott Laboratories | $37,223 | 0 |
| Nutritional Optimization in LVAD(NOL) Trial | Abbott Laboratories | $36,215 | 0 |
| CentriMag Failure-to-Wean Post Approval Study | Abbott Laboratories | $36,055 | 0 |
| Thoratec Corporation MOMENTUM 3, Multi-center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3 IDE Clinical Study Protocol | Abbott Laboratories | $29,225 | 0 |
| Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices (DOAC LVAD) | Abbott Laboratories | $25,000 | 0 |
| Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3 Continued Access Protocol: Post-Approval Continued Follow-up (MOMENTUM CAP-3) | Abbott Laboratories | $23,195 | 0 |
| Predicting the Risk of Right Ventricular Failure in Patients Undergoing Left Ventricular Assist Device Implantation | Abbott Laboratories | $20,973 | 0 |
| Effects of Home-based Exercise Rehabilitation on Activity Levels in Left Ventricular Assist Device Patients (MOVE-LVAD) | Abbott Laboratories | $17,350 | 0 |
Top Doctors Receiving Payments for THORATEC HEARTMATE 3 LVAS IMPLANT KIT
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Hartford, CT | $4.8M | 1,511 |
| , MD | Transplant Surgery | Dallas, TX | $80,113 | 116 |
| , MD | Cardiovascular Disease | Oklahoma City, OK | $73,814 | 131 |
| , PA | Physician Assistant | Rochester, MN | $72,812 | 243 |
| , M.D | Internal Medicine | Houston, TX | $56,394 | 85 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Atlanta, GA | $52,395 | 123 |
| , MD, PHD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Worcester, MA | $50,058 | 129 |
| , M.D | Internal Medicine | Temple, TX | $48,213 | 84 |
| Jonathan Grinstein | Advanced Heart Failure and Transplant Cardiology | Chicago, IL | $44,102 | 94 |
| , M.D., M.B.A | Student in an Organized Health Care Education/Training Program | Cleveland, OH | $41,614 | 111 |
| , MD | Pediatric Cardiology | Cincinnati, OH | $40,514 | 67 |
| Christopher Salerno | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Chicago, IL | $38,729 | 110 |
| , M.D | Advanced Heart Failure and Transplant Cardiology | New York, NY | $35,415 | 113 |
| , MD | Advanced Heart Failure and Transplant Cardiology | Detroit, MI | $34,009 | 79 |
| , MD | Interventional Cardiology | Sanford, NC | $33,173 | 10 |
| , MD | Surgery | New Orleans, LA | $32,749 | 69 |
| , MD | Advanced Heart Failure and Transplant Cardiology | Cincinnati, OH | $32,072 | 23 |
| , MD | Cardiovascular Disease | Austin, TX | $31,503 | 151 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Aurora, CO | $31,081 | 22 |
| , MD | Advanced Heart Failure and Transplant Cardiology | Robbinsville, NJ | $30,478 | 65 |
| , MD | Surgery | Orlando, FL | $30,298 | 80 |
| , MD | Internal Medicine | Rochester, NY | $29,613 | 97 |
| , MD | Cardiovascular Disease | Provo, UT | $29,500 | 2 |
| , M.D | Clinical Cardiac Electrophysiology | Littleton, CO | $27,313 | 7 |
| , M.D | Cardiovascular Disease | Roslyn, NY | $25,404 | 39 |
Ad
Manufacturing Companies
- Abbott Laboratories $9.9M
Product Information
- Type Device
- Total Payments $9.9M
- Total Doctors 9,492
- Transactions 42,230
About THORATEC HEARTMATE 3 LVAS IMPLANT KIT
THORATEC HEARTMATE 3 LVAS IMPLANT KIT is a device associated with $9.9M in payments to 9,492 healthcare providers, recorded across 42,230 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2022 to 2024. In 2024, $2.1M was paid across 12,517 transactions to 4,734 doctors.
The most common payment nature for THORATEC HEARTMATE 3 LVAS IMPLANT KIT is "Unspecified" ($4.6M, 46.2% of total).
THORATEC HEARTMATE 3 LVAS IMPLANT KIT is associated with 20 research studies, including "Antiplatelet Removal and HemocompatIbility Events in the HeartMate 3 Pump" ($2.1M).